To study the effect of repetitive transcranial magnetic stimulation and amitryptilline on migraine headache

Not Applicable

• Conditions: Health Condition 1: null- primary headache

• Registration Number: CTRI/2018/06/014542
• Lead Sponsor: Dr Jayantee Kalita

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

primary headache-migraine and chronic daily headache

Exclusion Criteria

All patients having any neurological morbidity due to any hereditary, trauma, seizure disorder, meningitis, arterio-veinous malformation, stroke, infection, dyselectrolytemia and any possible secondary cause of headache shall be excluded. Pregnancy, liver or kidney failure, malignancy, uncontrolled diabetis and hypertension or headache with underlying psychiatric illness shall be excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary out come will be defined as 50% decreases in severity and frequency of headache, at each follow-up visitTimepoint: 1 2 and 3 months

Secondary Outcome Measures

Name	Time	Method
Effects on habituation viz hearing threshold and brainstem evoked potentials and visual evoked potentials,Timepoint: 1 2 and 3 months